Table 1.
Characteristics of clinical/immunological failure patients with confirmed virological failure (HIV-1 RNA >1000 copies/ml) (n = 96).
| Variable | Median or percentage |
|---|---|
| Age (years) | 38 (IQR 31–45) |
| CD4 cell count (cells/μl) | 68 (IQR 23–174) |
| <50 | 44 |
| 51–200 | 35 |
| >200 | 21 |
| Log10 transformed HIV RNA (copies/ml) | 4.72 (IQR 4.26–5.16) |
| <10 000 | 16 |
| 10 001–100 000 | 54 |
| >100 000 | 30 |
| Time on ART (months) | 36.5 (IQR 26.6–49.8) |
| 0–24 | 20 |
| >24–36 | 29 |
| >36–48 | 22 |
| >48 | 29 |
| Clinical failure | 17 |
| Immunological failure | 91 |
| Lilongwe | 60 |
| Blantyre | 40 |
ART, antiretroviral therapy; IQR, interquartile range.